![](https://capedge.com/proxy/CORRESP/0001213900-22-065791/image_001.jpg)
650 Fifth Avenue, 35th Floor
New York, NY 10019
October 24, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | ASP Isotopes, Inc. (the “Company”) |
| Registration Statement on Form S-1 |
| File No. 333-267392 |
Ladies and Gentlemen:
Reference is made to our letter, submitted as a correspondence via EDGAR on October 21, 2022, in which we, as the representative of the underwriters of this public offering, requested the acceleration of the effective date of the above-referenced Registration Statement for Monday, October 24, 2022, at 4:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective pursuant to said request and we hereby formally withdraw said request for acceleration of the effective date.
Please also be advised that the Company is concurrently submitting, as of the even date hereof, a withdrawal of its request for acceleration of the effective date.
| Best Regards, |
| | |
| REVERE SECURITIES LLC |
| | |
| By: | /s/ Thomas Irwin |
| Name: | Thomas Irwin |
| Title: | Chief Operations Officer |